High-sensitivity C-reactive protein in type 2 diabetic patients with and without the metabolic syndrome

East African Medical Journal

Volumn 85, Issue 4, 2008, Pages 178-186

  Joshi, M D ^a   Wala, J ^a   Acharya, K S ^a   Amayo, A ^a  

^a UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 48849085707     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: 10.4314/eamj.v85i4.9642     Document Type: Article

References (22)

1. Howard, B.V., Rodriguez, B.L., Bennett, P.H., et al. Prevention Conference VI: Diabetes and cardiovascular disease. Writing Group I: epidemiology. Circulation. 2002; 105: e137.
2. Zimmet, P. Alberti, K.G. and Shaw, J. Global and societal implications of the diabetes epidemic. Nature. 2001; 414: 782-787.
3. The National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive summary of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Amer. Med. Ass. 2001; 285: 2486-2497.
4. Echel, R.H., Wassef, M., Chait, A., et al. Prevention Conference VI: Diabetes and cardiovascular. Writing Group II: pathogenesis of atherosclerosis in diabetes. Circulation. 2002; 105: e138-e143.
5. Hanson, G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Eng. J. Med. 2005; 352: 1685-1695.
6. Haverkate, F., Thompson, S.G., Pyke, S.D.M., et al: Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet. 1997; 349: 462-466.
7. Ridker, P.M., Wilson, P.W. and Grundy, S.M. Should C-reactive protein be added to the metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004; 109: 2818-2825.
8. Malik, S., Wong, N.D., Stanley, F., et al. Cardiovascular disease in US patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care. 2005; 28: 690-693.
9. Powers, A.C. Diabetes mellitus. In: Harrison's Principles of Internal Medicine, 16th ed, D. Kasper et al (eds). New York, McGraw-Hill, 2005.
10. Echel, R.H., Grundy, S.M., and Zimmet, P.Z. The metabolic syndrome. Lancet. 2005; 365: 1415-1428.
11. Yu, H. and Rifai, N. High-sensitivity C-reactive protein and atherosclerosis: From theory to therapy. Clin. Biochem. 2000; 33: 601-610.
12. Mwendwa, F.M., Otieno, C.F., Vaghela, V., et al. Risk factor profile and the occurrence of microvascular complications in short term type 2 diabetes mellitus at Kenyatta National Hospital, Nairobi. East Afr. Med. J. 82: s163-s172.
13. Otieno, C.F., Vaghela V., Mwendwa F.M., et al. Cardiovascular risk Factors in patients with type 2 diabetes mellitus in Kenya: Level of control attained at the outpatient diabetic clinic of Kenyatta National Hospital. East Afr. Med. J. 82: s184-s190.
14. Woloshin, S. and Schwartz, L.M. Distribution of CRP values in the United States. N. Eng. J. Med. 2005; 352: 1611-1612.
15. Yeh, E.T. and Willerson, J.J. Coming of age of CRP. Circulation. 2003; 107: 370-372.
16. Schulze, M.B., Rimm ,E.B., Li, T., et al. C-reactive protein and incident cardiovascular events among men with diabetes. Diabetes Care. 2004; 27: 889-894.
17. Isomaa, B., Alingren, P., Tuomi, T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001; 24: 603-609.
18. Grundy, S.M. The metabolic syndrome still lives. Clin. Chem. 2005; 51: 1352-1357.
19. Reaven, G.M. The metabolic syndrome: Requiescat in pace. Clin. Chem. 2005; 51: 931-938.
20. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF, 2005. Available at: http://www.idforg/webdata/docs/IDFMetasyndromedefinition.pdf (accessed May 2006).
21. Wilson, P.W., D'Agostino, R.B., Levy, D., et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-1847.
22. Frohlich, M., Imhof, A., Berg, G., et al. Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care. 2000; 23: 1835-1839.